- Study finds mRNA boosters were highly effective against symptomatic delta infection, but they were less effective against symptomatic omicron infection. However, with both variants, mRNA boosters led to strong protection against Covid-19–related hospitalization and death. https://www.nejm.org/doi/full/10.1056/NEJMoa2200797 43 comments science
Linking pages
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2203965 15 comments
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections | NEJM https://doi.org/10.1056/NEJMoa2203965 15 comments
- Vaccines | Free Full-Text | Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review https://www.mdpi.com/2076-393X/11/1/24 9 comments
Linked pages
- Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections | NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2108120 174 comments
- BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2115624 69 comments
- A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208343 33 comments
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2035389 18 comments
- Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2115481?query=featured_home 14 comments
- Universal Coronavirus Vaccines — An Urgent Need | NEJM https://www.nejm.org/doi/full/10.1056/NEJMp2118468 1 comment
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 1 comment
- Congenital Hypermetabolism and Uncoupled Oxidative Phosphorylation | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2202949?query=featured_home 1 comment
- Tracking SARS-CoV-2 variants https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ 0 comments
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2114114 0 comments
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants | NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2104974 0 comments
Related searches:
Search whole site: site:www.nejm.org
Search title: Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM
See how to search.